Transformation of Epithelial Cell by E6 Oncogene
E6癌基因对上皮细胞的转化
基本信息
- 批准号:6752507
- 负责人:
- 金额:$ 28.26万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-06-01 至 2008-05-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): Cervical carcinomas are associated with a few specific subtypes of the human papillomavirus (HPV). However, the molecular mechanisms of cellular transformation by these "high-risk" HPV are not fully understood. Two transforming oncoproteins of HPV, E6 and E7, are required for both initiation and maintenance of cellular transformation. The transforming function of E6 is mediated partially by its ability to induce ubiquitination and degradation of the p53 tumor suppressor protein. However, E6 also has poorly understood transformation activities that are p53-independent. These additional E6 activities have critical roles in the pathogenesis of cancers caused by HPV. Recently, we cloned and characterized a novel human E6-binding protein, MAML1 (mastermind-like-I) that selectively interacts with E6 from high-risk HPV type 16. MAML1 is related to the Drosophila melanogaster mastermind gene, a component of the Notch signaling pathway involved in cell fate determination. We found that MAML1, a nuclear protein, functions as a transcriptional co-activator for mammalian Notch receptors. These studies have now led to our cloning and characterization of two additional members of this novel mammalian mastermind family, MAML2 and MAML3. Like MAML1, both MAML2 and MAML3 preferentially bind to E6 from high-risk HPV16. Furthermore, high-risk HPV16 E6 proteins block Notch signaling. Therefore, the MAML family provides the first direct link between papillomavirus oncoproteins and the Notch pathway. The, goal of this proposal is to determine the mechanisms and significance of the HPV E6 interactions with the three mammalian mastermind family members in E6-mediated cellular transformation. The hypothesis to be tested is that HPV E6 interactions with the Notch pathway, via the MAML family, have a critical role in cellular transformation. Specifically, we hypothesize that E6-MAML interactions result in altered Notch signaling and lead to deregulated growth and differentiation in cervical epithelial cells. Alternatively or in combination, E6-MAML interactions may be required for E6 transformation activities involving cell proliferation, cell cycle regulation and senescence. To test these hypotheses, we will 1) determine whether the interactions of high-risk E6 proteins with MAML proteins are critical for E6 mediated cellular transformation, 2) determine whether and how the interactions of E6 and MAML proteins contribute to cellular transformation via Notch signaling. The proposed research will advance our understanding of the molecular mechanisms of transformation of cervical cancers, as well as provide insight into the novel MAML family and the Notch signaling pathway.
描述(由申请人提供):宫颈癌与人乳头瘤病毒(HPV)的一些特定亚型有关。 但是,这些“高风险” HPV的细胞转化的分子机制尚未完全了解。 HPV,E6和E7的两个转化癌蛋白是细胞转化的启动和维持所必需的。 E6的转化功能部分是由于其诱导p53肿瘤抑制蛋白的泛素化和降解的能力而部分介导的。但是,E6也对独立于p53的转型活动也很少理解。这些额外的E6活性在由HPV引起的癌症的发病机理中具有关键作用。最近,我们克隆并表征了一种新型的人类E6结合蛋白MAML1(Mastermind-like-I),该蛋白与高风险HPV类型16型与E6有选择地相互作用。MAML1与果蝇Melanogaster Mastermind Gene有关,这是细胞效果确定的Notch信号途径的成分。我们发现MAML1是一种核蛋白,是哺乳动物缺口受体的转录共激活剂。这些研究现在导致了我们对这个新型哺乳动物策划家族MAML2和MAML3的另外两个成员的克隆和表征。像MAML1一样,MAML2和MAML3都优先结合了高风险HPV16的E6。此外,高风险的HPV16 E6蛋白会阻止Notch信号传导。因此,MAML家族提供了乳头瘤病毒癌蛋白和Notch途径之间的第一个直接联系。该提案的目标是确定HPV E6相互作用与E6介导的细胞转化中三个哺乳动物策划者家族成员的机制和意义。要检验的假设是,通过MAML家族,HPV E6与Notch途径的相互作用在细胞转化中具有关键作用。具体而言,我们假设E6-MAML相互作用会导致Notch信号变化,并导致颈椎上皮细胞的生长和分化。替代地或组合,涉及细胞增殖,细胞周期调节和衰老的E6转化活动可能需要E6-MAML相互作用。为了检验这些假设,我们将1)确定高危E6蛋白与MAML蛋白的相互作用对于E6介导的细胞转化至关重要,2)确定E6和MAML蛋白的相互作用是否以及如何通过Notch信号导致细胞转化。拟议的研究将提高我们对宫颈癌转化的分子机制的理解,并提供对新型MAML家族和Notch信号通路的见解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Lizi Wu其他文献
Lizi Wu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Lizi Wu', 18)}}的其他基金
Aberrant CRTC activation as a unique vulnerability of lung cancer with LKB1 inactivation
CRTC 异常激活是 LKB1 失活肺癌的独特弱点
- 批准号:
10334407 - 财政年份:2019
- 资助金额:
$ 28.26万 - 项目类别:
Aberrant CRTC activation as a unique vulnerability of lung cancer with LKB1 inactivation
CRTC 异常激活是 LKB1 失活肺癌的独特弱点
- 批准号:
10558734 - 财政年份:2019
- 资助金额:
$ 28.26万 - 项目类别:
A novel noncoding RNA and human lung cancers with inactivated LKB1 signaling
一种新型非编码 RNA 与 LKB1 信号失活的人类肺癌
- 批准号:
8881623 - 财政年份:2015
- 资助金额:
$ 28.26万 - 项目类别:
Signaling and targeting of CRTC1-MAML2 fusion oncoprotein in salivary gland tumor
CRTC1-MAML2融合癌蛋白在唾液腺肿瘤中的信号传导和靶向
- 批准号:
8696318 - 财政年份:2014
- 资助金额:
$ 28.26万 - 项目类别:
Signaling and Targeting of CRTC1-MAML2 Fusion Oncoprotein in Salivary Gland
唾液腺中 CRTC1-MAML2 融合癌蛋白的信号传导和靶向
- 批准号:
10439473 - 财政年份:2014
- 资助金额:
$ 28.26万 - 项目类别:
Signaling and Targeting of CRTC1-MAML2 Fusion Oncoprotein in Salivary Gland
唾液腺中 CRTC1-MAML2 融合癌蛋白的信号传导和靶向
- 批准号:
10208855 - 财政年份:2014
- 资助金额:
$ 28.26万 - 项目类别:
Signaling and targeting of CRTC1-MAML2 fusion oncoprotein in salivary gland tumor
CRTC1-MAML2融合癌蛋白在唾液腺肿瘤中的信号传导和靶向
- 批准号:
8907995 - 财政年份:2014
- 资助金额:
$ 28.26万 - 项目类别:
Signaling and Targeting of CRTC1-MAML2 Fusion Oncoprotein in Salivary Gland
唾液腺中 CRTC1-MAML2 融合癌蛋白的信号传导和靶向
- 批准号:
10672248 - 财政年份:2014
- 资助金额:
$ 28.26万 - 项目类别:
Transformation of Epithelial Cell by E6 Oncogene
E6癌基因对上皮细胞的转化
- 批准号:
7317800 - 财政年份:2003
- 资助金额:
$ 28.26万 - 项目类别:
相似国自然基金
基于三维结构表征学习的RNA结合蛋白绑定位点预测算法研究
- 批准号:62202152
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
基于三维结构表征学习的RNA结合蛋白绑定位点预测算法研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于深度学习的转录因子绑定位点预测方法研究
- 批准号:62002266
- 批准年份:2020
- 资助金额:24 万元
- 项目类别:青年科学基金项目
海量多源互补蛋白质数据的配体绑定位点预测研究
- 批准号:61902352
- 批准年份:2019
- 资助金额:27.0 万元
- 项目类别:青年科学基金项目
用dsDNA微阵列筛选NF-κB DNA靶点及靶基因
- 批准号:60871014
- 批准年份:2008
- 资助金额:35.0 万元
- 项目类别:面上项目
相似海外基金
A role for cardiomyocyte pannexin 1 in non-ischemic heart failure
心肌细胞pannexin 1在非缺血性心力衰竭中的作用
- 批准号:
10680109 - 财政年份:2023
- 资助金额:
$ 28.26万 - 项目类别:
Computer-aided design and development of isoform selective inhibitors of Casein Kinase 1
酪蛋白激酶 1 异构体选择性抑制剂的计算机辅助设计和开发
- 批准号:
10629703 - 财政年份:2023
- 资助金额:
$ 28.26万 - 项目类别:
Role of miR-195 in Chemo-Resistant Ovarian Cancer
miR-195 在化疗耐药性卵巢癌中的作用
- 批准号:
10640540 - 财政年份:2023
- 资助金额:
$ 28.26万 - 项目类别:
Uncovering the Role of the MS4A Gene Family in Alzheimer's Disease
揭示 MS4A 基因家族在阿尔茨海默病中的作用
- 批准号:
10751885 - 财政年份:2023
- 资助金额:
$ 28.26万 - 项目类别:
Molecular mechanism of membrane association of Bruton's Tyrosine Kinase
布鲁顿酪氨酸激酶膜缔合的分子机制
- 批准号:
10604872 - 财政年份:2023
- 资助金额:
$ 28.26万 - 项目类别: